India  

WHO Chief Scientist Dr Swaminathan says phase-3 trials of Covaxin look good, Bharat Biotech awaits approval

DNA Friday, 9 July 2021
A few days ago, Bharat Biotech had released the phase 3 clinical trial results of Covaxin after evaluating 130 symptomatic COVID-19 cases.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 | Oneindia News

ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 | Oneindia News 02:35

The Indian Space Research Organisation is getting back into launch activity at Sriharikota spaceport; Today in the afternoon, three militants were killed in an encounter with security forces in Anantnag district of Jammu and Kashmir; WHO chief scientist Soumya Swaminathan has said that the...

💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

Need more info, can’t cut corners on Covaxin: WHO

The WHO said on Monday it was “aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the Covid-19 emergency use listing..
IndiaTimes

Cannot cut corners, need to thoroughly evaluate product before recommending emergency use: WHO on Covaxin

The WHO on Monday said it cannot cut corners and needs to thoroughly evaluate a product before recommending it for EUL to ensure it is safe and effective. “We..
IndiaTimes

Covaxin's approval for children aged 2-18 years under experts' opinion, evaluation: Sources

The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday...
IndiaTimes

India resumes vaccine exports as domestic stocks build up: Officials

One million shots of Covaxin produced by Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said. Vaccines have also been sent to Nepal,..
IndiaTimes

World Health Organization World Health Organization Specialized agency of the United Nations

WHO's technical advisory group to meet on Oct 26 to take call on Covaxin EUL

In a tweet late on Sunday night, World Health Organisation (WHO) chief scientist Soumya Swaminathan said, "WHO has been working closely with Bharat Biotech to..
IndiaTimes

COVID-19: New WHO team may be 'last chance' to understand origins of coronavirus

A newly formed World Health Organisation (WHO) team may be "our last chance" to understand the origins of coronavirus, the body's top emergency expert has said.
Sky News
Last clue to Covid-19 origins may sit in Wuhan hospital [Video]

Last clue to Covid-19 origins may sit in Wuhan hospital

China is preparing to test thousands of blood samples from the city of Wuhan as part of the probe into the origins of Covid-19, but as CNN’s Nick Paton Walsh reports, the World Health Organization and other foreign experts will not be allowed to analyze the data independently.

Credit: Bleacher Report AOL    Duration: 03:28Published

COVID to cause 'surges of illness' for 'months and perhaps years to come', WHO expert warns

"Surges of illness" caused by COVID-19 are going to continue for "months and perhaps even years to come", the World Health Organization's (WHO) special envoy for..
Sky News

Bharat Biotech Bharat Biotech Indian multinational biotechnology company and vaccine manufacturer

Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News [Video]

Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News

In a big development today, the Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Meanwhile, Congress leader Priyanka Gandhi Vadra has reached Tikoniua to pay last respect to farmers who were killed in the October 3rd violence in Lakhimpur Kheri. Watch the video for this and more news at 2 PM. #Covaxin #IndianArmy #Farmers

Credit: Oneindia    Duration: 03:37Published
WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News [Video]

WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News

An expert panel of the WHO is going to take a decision on emergency use listing authorisation of Bharat Biotech’s Covaxin tentatively at 4:45 pm today. #Covaxin #WHO #EUL

Credit: Oneindia    Duration: 01:23Published

You Might Like


Related videos from verified sources

PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News [Video]

PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News

Today, the Monsoon session of the Lok Sabha began on a chaotic note with the opposition preventing Prime Minister Narendra Modi from introducing his newly-inducted Union ministers to the House; The..

Credit: Oneindia     Duration: 02:22Published
Covaxin approval: WHO chief scientist says Phase-3 data looks promising| Covid-19| Oneindia News [Video]

Covaxin approval: WHO chief scientist says Phase-3 data looks promising| Covid-19| Oneindia News

WHO Chief Scientist Soumya Swaminathan has said Covaxin's Phase-3 data looks promising and the vaccine can hopefully be approved by the WHO by mid to late August. Senior Advocate Harish Salve on Friday..

Credit: Oneindia     Duration: 02:46Published
Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News [Video]

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News

Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8% effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides..

Credit: Oneindia     Duration: 02:13Published

Related news from verified sources

TOI EXCLUSIVE: Over 6,000 certified Covid deaths missing from Kerala’s official toll

A​s of June 30, 2021, Kerala's official Covid toll put out by the state health department has failed to include over 6,000 Covid-19 deaths that have been duly...
IndiaTimes

Google brings support for digital COVID vaccine cards on Android: How to store on your device

In an interesting move, Google has updated its passes API system to allow Android users to save and access a digital copy of their COVID-19 vaccine cards. The...
BGR India

My COVID Story: The virus took a full four-week beating on my body

Rahul Ganju never stepped outside unlike multitude of people and his family strictly adhered to all COVID appropriate behaviour. However, he caught COVID from a...
IndiaTimes